S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NYSE:CIM

Chimera Investment - CIM Stock Forecast, Price & News

$6.66
-0.11 (-1.62%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$6.64
▼
$6.81
50-Day Range
$5.03
▼
$6.97
52-Week Range
$4.91
▼
$16.31
Volume
992,747 shs
Average Volume
2.39 million shs
Market Capitalization
$1.54 billion
P/E Ratio
N/A
Dividend Yield
13.59%
Price Target
$7.83

Chimera Investment MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
17.6% Upside
$7.83 Price Target
Short Interest
Healthy
4.57% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.09
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
-18.85%
From $1.22 to $0.99 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.75 out of 5 stars

Finance Sector

793rd out of 889 stocks

Real Estate Investment Trusts Industry

168th out of 191 stocks

See Top Rated MarketRank™ Stocks Here
CIM stock logo

About Chimera Investment (NYSE:CIM) Stock

Chimera Investment Corporation operates as an internally-managed real estate investment trust (REIT) in the United States. The company was incorporated in 2007 with the purpose of investing in mortgage loans, asset securitization, and mortgage-backed securities.

Chimere Investment Corporation is based in New York, New York, trades on the New York Stock Exchange, and works to provide attractive risk-adjusted returns via dividends and capital preservation. As of late 2022, the company had more than $3 billion in capitalization including common and preferred stock, and had paid more than $5.8 billion in dividends.

The company has elected to be taxed as a REIT which is a tax-sheltered vehicle for real estate investment. As such, the company must invest at least 75% of its assets in real estate and return 90% of its taxable income to shareholders in the form of dividends. The only drawback is that shareholders are responsible for income taxes on the earnings.

The company’s strategy is to invest in a portfolio of mortgage assets, including residential mortgage loans, agency, and non-agency residential mortgage-backed securities, and agency commercial mortgage-backed securities. Income is generated by the net spread between the income earned on investments and the costs of financing.

Chimera Investment Corporation finances its operations through secured pools of residential and commercial mortgage loans and by leveraging other real estate-related securities as well. The strategy not only provides a stable source of financing but also provides the flexibility to enhance returns or mitigate risk as necessary.

One risk of Chimera Investment Corporation is its exposure to US credit risk retention rules. These rules limit the company’s ability to sell or hedge a large portion of its RMBS portfolio which means it may have to hold some assets it would otherwise sell. In regard to portfolio diversification, RMBS historically make up about 11% of the portfolio while securitized loans comprise 80% to 90% of total holdings.

Chimera Investment Corporation investors may participate in a share repurchase plan as well. Investors of Record can participate directly in the plan while Beneficial Owners may request their shares be transferred to the agent of record and become Investors of Record.

Receive CIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chimera Investment and its competitors with MarketBeat's FREE daily newsletter.

CIM Stock News Headlines

November 17, 2022 | finance.yahoo.com
Chimera Declares Fourth Quarter 2022 Common Stock Dividend
November 3, 2022 | seekingalpha.com
Chimera Investment Corporation (CIM) Q3 2022 Earnings Call Transcript
November 3, 2022 | seekingalpha.com
Chimera Investment stock dives after Q3 NII miss, more pressure on book value
November 3, 2022 | finance.yahoo.com
Chimera Declares Fourth Quarter 2022 Preferred Stock Dividends
November 3, 2022 | finance.yahoo.com
CHIMERA INVESTMENT CORPORATION REPORTS 3RD QUARTER 2022 EARNINGS
November 3, 2022 | finance.yahoo.com
Chimera Investment (CIM) Q3 Earnings and Revenues Beat Estimates
October 26, 2022 | seekingalpha.com
CIM Chimera Investment Corporation
October 25, 2022 | nasdaq.com
Notable Monday Option Activity: CIM, PII, TTWO
October 20, 2022 | seekingalpha.com
CIM.PC Chimera Investment Corporation 7.75% CUM PFD C
October 19, 2022 | finance.yahoo.com
Chimera Investment Corporation Announces Date of Third Quarter 2022 Financial Results and Conference Call
October 18, 2022 | finance.yahoo.com
Chimera Investment (NYSE:CIM) shareholders are up 11% this past week, but still in the red over the last three years
October 13, 2022 | nasdaq.com
Chimera Investment (NYSE:CIM) shareholders have endured a 63% loss from investing in the stock three years ago
October 11, 2022 | seekingalpha.com
CIM.PD Chimera Investment Corporation 8% PFD CUM SER D
October 7, 2022 | finance.yahoo.com
Here's Why Dividend Cuts Are a Risk for Mortgage REITs
October 5, 2022 | nasdaq.com
Wednesday's ETF Movers: PBUS, REM
September 28, 2022 | finance.yahoo.com
Chimera Investment Corporation (CIM-PB)
September 23, 2022 | nasdaq.com
Notable Thursday Option Activity: CIM, NFLX, MSTR
September 21, 2022 | finance.yahoo.com
Chimera Declares Third Quarter 2022 Common Stock Dividend
September 15, 2022 | seekingalpha.com
Chimera Investment: A Dividend Cut May Be Coming
September 11, 2022 | thestreet.com
Chimera Investment (CIM) Stock Dropping on Deutsche Bank Price Target Cut
September 2, 2022 | seekingalpha.com
Chimera Preferreds Offer Value; The Common Does Not
September 2, 2022 | nasdaq.com
Chimera Investment is Oversold
August 25, 2022 | finance.yahoo.com
Clearwater Analytics Powers Sophisticated REIT Accounting and Reporting for New York-based Chimera
August 4, 2022 | seekingalpha.com
Chimera Investment trades lower after Y/Y fall in Q2 earnings
August 4, 2022 | finance.yahoo.com
Chimera Declares Third Quarter 2022 Preferred Stock Dividends
See More Headlines
Receive CIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chimera Investment and its competitors with MarketBeat's FREE daily newsletter.

CIM Company Calendar

Ex-Dividend for 10/31 Dividend
9/29/2022
Dividend Payable
10/31/2022
Last Earnings
11/03/2022
Today
12/09/2022
Ex-Dividend for 1/31 Dividend
12/29/2022
Fiscal Year End
12/31/2022
Dividend Payable
1/31/2023
Next Earnings (Estimated)
2/16/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Real estate investment trusts
Sub-Industry
Mortgage REITs
Sector
Finance
Current Symbol
NYSE:CIM
CUSIP
16934Q10
CIK
1409493
Web
www.chimerareit.com
Phone
(212) 626-2300
Fax
212-696-9809
Employees
38
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.83
High Stock Price Forecast
$9.00
Low Stock Price Forecast
$7.00
Forecasted Upside/Downside
+17.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($2.83)
Trailing P/E Ratio
N/A
Forward P/E Ratio
5.46
P/E Growth
N/A
Net Income
$670.11 million
Net Margins
-73.42%
Pretax Margin
-73.51%
Return on Equity
13.06%
Return on Assets
2.84%

Debt

Debt-to-Equity Ratio
3.87
Current Ratio
3.24
Quick Ratio
3.24

Sales & Book Value

Annual Sales
$937.55 million
Price / Sales
1.65
Cash Flow
$2.46 per share
Price / Cash Flow
2.71
Book Value
$15.77 per share
Price / Book
0.42

Miscellaneous

Outstanding Shares
231,754,000
Free Float
230,665,000
Market Cap
$1.54 billion
Optionable
Optionable
Beta
1.34

Key Executives

  • Mr. Mohit Marria (Age 44)
    CEO, Chief Investment Officer & Director
    Comp: $5.39M
  • Mr. Choudhary Yarlagadda (Age 60)
    Pres, COO & Director
    Comp: $4.94M
  • Mr. Subramaniam Viswanathan (Age 50)
    Chief Financial Officer
    Comp: $1.5M
  • Mr. Phillip John Kardis II (Age 61)
    Esq., Chief Legal Officer & Corp. Sec.
    Comp: $4.2M
  • Mr. Kelley Kortman (Age 51)
    Chief Accounting Officer
  • Ms. Emily Mohr
    Investor Relations Officer
  • Victor Falvo
    Head of Capital Markets
  • Mr. Dan Thakkar
    Chief Risk Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CIM Stock - Frequently Asked Questions

Should I buy or sell Chimera Investment stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Chimera Investment in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CIM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CIM, but not buy additional shares or sell existing shares.
View CIM analyst ratings or view top-rated stocks.

What is Chimera Investment's stock price forecast for 2023?

2 brokers have issued 1 year price targets for Chimera Investment's stock. Their CIM share price forecasts range from $7.00 to $9.00. On average, they anticipate the company's share price to reach $7.83 in the next year. This suggests a possible upside of 17.6% from the stock's current price.
View analysts price targets for CIM or view top-rated stocks among Wall Street analysts.

How have CIM shares performed in 2022?

Chimera Investment's stock was trading at $15.08 at the beginning of the year. Since then, CIM shares have decreased by 55.8% and is now trading at $6.66.
View the best growth stocks for 2022 here.

Are investors shorting Chimera Investment?

Chimera Investment saw a decrease in short interest in October. As of October 31st, there was short interest totaling 10,890,000 shares, a decrease of 15.2% from the October 15th total of 12,840,000 shares. Based on an average trading volume of 2,890,000 shares, the short-interest ratio is currently 3.8 days. Approximately 4.8% of the company's shares are sold short.
View Chimera Investment's Short Interest.

When is Chimera Investment's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our CIM earnings forecast.

How were Chimera Investment's earnings last quarter?

Chimera Investment Co. (NYSE:CIM) issued its quarterly earnings data on Thursday, November, 3rd. The real estate investment trust reported $0.27 earnings per share for the quarter, beating the consensus estimate of $0.25 by $0.02. Chimera Investment had a positive trailing twelve-month return on equity of 13.06% and a negative net margin of 73.42%. During the same period in the prior year, the company earned $0.42 earnings per share.

How often does Chimera Investment pay dividends? What is the dividend yield for Chimera Investment?

Chimera Investment declared a quarterly dividend on Thursday, November 17th. Stockholders of record on Friday, December 30th will be given a dividend of $0.23 per share on Tuesday, January 31st. This represents a $0.92 dividend on an annualized basis and a dividend yield of 13.81%. The ex-dividend date is Thursday, December 29th.
Read our dividend analysis for CIM.

Is Chimera Investment a good dividend stock?

Chimera Investment (NYSE:CIM) pays an annual dividend of $0.92 per share and currently has a dividend yield of 13.59%. CIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for CIM.

What is Matthew Lambiase's approval rating as Chimera Investment's CEO?

3 employees have rated Chimera Investment Chief Executive Officer Matthew Lambiase on Glassdoor.com. Matthew Lambiase has an approval rating of 100% among the company's employees. This puts Matthew Lambiase in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Chimera Investment own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chimera Investment investors own include New Residential Investment (NRZ), Annaly Capital Management (NLY), Marathon Oil (MRO), AGNC Investment (AGNC), Energy Transfer (ET), AT&T (T), ARMOUR Residential REIT (ARR), New York Mortgage Trust (NYMT), Enterprise Products Partners (EPD) and NGL Energy Partners (NGL).

What is Chimera Investment's stock symbol?

Chimera Investment trades on the New York Stock Exchange (NYSE) under the ticker symbol "CIM."

Who are Chimera Investment's major shareholders?

Chimera Investment's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (9.55%), BlackRock Inc. (8.17%), Centiva Capital LP (0.00%), State Street Corp (2.31%), Leeward Investments LLC MA (1.25%) and Nomura Holdings Inc. (0.00%). Insiders that own company stock include Choudhary Yarlagadda, Kelley Kortman, Matthew Lambiase, Paul Donlin, Phillip John Kardis II and Robert S Colligan.
View institutional ownership trends.

How do I buy shares of Chimera Investment?

Shares of CIM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Chimera Investment's stock price today?

One share of CIM stock can currently be purchased for approximately $6.66.

How much money does Chimera Investment make?

Chimera Investment (NYSE:CIM) has a market capitalization of $1.54 billion and generates $937.55 million in revenue each year. The real estate investment trust earns $670.11 million in net income (profit) each year or ($2.83) on an earnings per share basis.

How can I contact Chimera Investment?

Chimera Investment's mailing address is 520 MADISON AVENUE 32ND FLOOR, NEW YORK NY, 10022. The official website for the company is www.chimerareit.com. The real estate investment trust can be reached via phone at (212) 626-2300, via email at investor@chimerareit.com, or via fax at 212-696-9809.

This page (NYSE:CIM) was last updated on 12/9/2022 by MarketBeat.com Staff